... and lung transplants—who receive the most intensive immunosuppressive regimens—are most likely to develop EBV-LPD, particularly Chapter 126. Infections in Transplant Recipients (Part 7) Adenovirus ... therapy (when indicated), and rapid diagnosis and treatment of infections can be lifesaving in SOT recipients, who, unlike most HSCT recipients, continue to be immunosuppressed. SOT recipients ... (Chap. 1 77). Intranasal pleconaril, a capsid-binding agent, is being studied for the treatment of enterovirus infection. Rhinoviruses and coronaviruses are frequent co-pathogens in HSCT recipients; ...